Ebola virus disease
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
SARS-CoV-2 and coronavirus disease 2019: what we know so far
FA Rabi, MS Al Zoubi, GA Kasasbeh, DM Salameh… - Pathogens, 2020 - mdpi.com
In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They
were caused by a previously unknown coronavirus. All patients had been associated with …
were caused by a previously unknown coronavirus. All patients had been associated with …
Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial
Importance Convalescent plasma is a potential therapeutic option for patients with
coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are …
coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are …
Treatment of 5 critically ill patients with COVID-19 with convalescent plasma
C Shen, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific
therapeutic agents and substantial mortality. It is critical to find new treatments. Objective To …
therapeutic agents and substantial mortality. It is critical to find new treatments. Objective To …
[HTML][HTML] Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
RL Kruse - F1000Research, 2020 - ncbi.nlm.nih.gov
Abstract A novel coronavirus (2019-nCoV) originating in Wuhan, China presents a potential
respiratory viral pandemic to the world population. Current efforts are focused on …
respiratory viral pandemic to the world population. Current efforts are focused on …
[HTML][HTML] Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future …
Abstract Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …
Convalescent plasma to treat COVID-19: possibilities and challenges
In this issue of JAMA, Shen et al report findings from a preliminary study of 5 severely ill
patients with coronavirus disease 2019 (COVID-19) who were treated in the Shenzhen Third …
patients with coronavirus disease 2019 (COVID-19) who were treated in the Shenzhen Third …
[HTML][HTML] COVID-19 challenges and its therapeutics
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …
death worldwide, making it one of the severe public health issues in recent decades. nCoV …
[HTML][HTML] Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
G Zhou, Q Zhao - International Journal of Biological Sciences, 2020 - ncbi.nlm.nih.gov
A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated
respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the …
respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the …
COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection
In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …